Postoperative shock

description: A state of shock following a surgical operation.


name: Stage II Appendix Neuroendocrine Tumor AJCC v7

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: Stage II includes: T2, T3, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm or with extension to the cecum. T3: Tumor more than 4 cm or with extension to the ileum.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)


name: DNA-directed RNA polymerases I, II, and III subunit RPABC1 isoform 1 (human)

description: A DNA-directed RNA polymerases I, II, and III subunit RPABC1 isoform 1 that is encoded in the genome of human.


name: DNA-directed RNA polymerases I, II, and III subunit RPABC1 deaminated 1 (human)

description: A DNA-directed RNA polymerases I, II, and III subunit RPABC1 (human) that has been deaminated on the residue at the position equivalent to Gln-95 of the amino acid sequence represented by UniProtKB:P19388. UniProtKB:P19388, Gln-95, MOD:00685.


name: disintegrin and metalloproteinase domain-containing protein 22 methylated 1 (human)

description: A disintegrin and metalloproteinase domain-containing protein 22 (human) that has been methylated on the residue at the position equivalent to Cys-349 of the amino acid sequence represented by UniProtKB:Q9P0K1-1. Example: UniProtKB:Q9P0K1-1, Cys-349, MOD:00660.


name: follitropin subunit beta N-glycosylated 10 (human)

description: A follitropin subunit beta (human) that has been N-glycosylated at the residue equivalent to Asn-42 of the amino acid sequence represented by UniProtKB:P01225-1, in which the glycan structure is represented by GlyTouCan:G50131RA. Example: UniProtKB:P01225-1, Asn-42, MOD:00160~GNO:G50131RA.


name: E3 ubiquitin-protein ligase UHRF1 deaminated 1 (human)

description: An E3 ubiquitin-protein ligase UHRF1 (human) that has been deaminated on the residue at the position equivalent to Asn-775 of the amino acid sequence represented by UniProtKB:Q96T88-1. Example: UniProtKB:Q96T88-1, Asn-775, MOD:00684.


name: keratin, type I cuticular Ha5 isoform 1 (human)

description: A keratin, type I cuticular Ha5 isoform 1 that is encoded in the genome of human.


name: COMM domain-containing protein 3 isoform 1 (human)

description: A COMM domain-containing protein 3 isoform 1 that is encoded in the genome of human.


name: double-stranded RNA-specific editase 1 isoform h1 (human)

description: A double-stranded RNA-specific editase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P78563-1.


name: double-stranded RNA-specific editase 1 isoform 2 (human)

description: A double-stranded RNA-specific editase 1 isoform 2 that is encoded in the genome of human.


name: double-stranded RNA-specific editase 1 isoform h3 (human)

description: A double-stranded RNA-specific editase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P78563-3.


name: double-stranded RNA-specific editase 1 isoform h4 (human)

description: A double-stranded RNA-specific editase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P78563-4.


name: double-stranded RNA-specific editase 1 isoform h5 (human)

description: A double-stranded RNA-specific editase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P78563-5.


name: double-stranded RNA-specific editase 1 isoform h6 (human)

description: A double-stranded RNA-specific editase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P78563-6.


Adult Ependymoma

description: An ependymoma occurring in adults.


name: Adult Supratentorial Ependymoma ZFTA Fusion-Positive

description: A supratentorial ependymoma ZFTA fusion-positive that occurs in adults.


Adult Posterior Fossa Ependymoma

description: A posterior fossa ependymoma that occurs in adults.


cytochrome P450 2S1

A protein that is a translation product of the human CYP2S1 gene or a 1:1 ortholog thereof.


cytochrome P450 2S1 isoform h2 (human)

A cytochrome P450 2S1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96SQ9-2.


cytochrome P450 2S1 isoform h1 (human)

A cytochrome P450 2S1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96SQ9-1.


name: isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial cysteinylated 1 (human)

description: An isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (human) that has been cysteinylated on the residue at the position equivalent to Cys-236 of the amino acid sequence represented by UniProtKB:P50213-1. Example: UniProtKB:P50213-1, Cys-236, MOD:00765.


name: isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial, transit peptide removed form (human)

description: An isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (human) that has had the transit peptide removed. UniProtKB:P50213, 28-366.


name: isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial isoform 1 (human)

description: An isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial isoform 1 that is encoded in the genome of human.


name: isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial methylated 1 (human)

description: An isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (human) that has been methylated on the residue at the position equivalent to Cys-127 of the amino acid sequence represented by UniProtKB:P50213-1. Example: UniProtKB:P50213-1, Cys-127, MOD:00660.


name: isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial isoform 2 (human)

description: An isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial isoform 2 that is encoded in the genome of human.


name: hereditary continuous muscle fiber activity

description: Hereditary continuous muscle fiber activity is a rare, non-dystrophic myopathy characterized by generalized myokymia and increased muscle tone associated with delayed motor milestones, leg stiffness, spastic gait, hyperreflexia and Babinski sign. Symptoms may be worsened by febrile illness or anesthesia.


Advanced Genitourinary System Carcinoma

description: A genitourinary system carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Bladder Urothelial Carcinoma

description: Bladder urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Urethral Urothelial Carcinoma

description: A urethral urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Vaginal Adenosquamous Carcinoma

description: Vaginal adenosquamous carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Endometrial Carcinoma

description: An endometrial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Fallopian Tube Carcinoma

description: Fallopian tube carcinoma that has spread extensively from its original site of growth to other anatomic sites or is no longer responding to treatment.


Advanced Ureter Urothelial Carcinoma

description: Ureter urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Cervical Squamous Cell Carcinoma

description: Cervical squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Penile Carcinoma

description: Penile carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Vaginal Squamous Cell Carcinoma

description: Vaginal squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Cervical Carcinoma

description: A cervical carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Platinum-Refractory Ovarian Carcinoma

description: Platinum-refractory ovarian carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Bladder Carcinoma

description: A bladder carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Platinum-Resistant Ovarian Carcinoma

description: Platinum-resistant ovarian carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Ovarian Carcinoma

description: An ovarian carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Urothelial Carcinoma

description: Urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Renal Pelvis and Ureter Urothelial Carcinoma

description: Renal pelvis and ureter urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Microsatellite Stable Ovarian Carcinoma

description: Microsatellite stable ovarian carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Microsatellite Stable Endometrial Carcinoma

description: Microsatellite stable endometrial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Vaginal Carcinoma

description: Vaginal carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Endometrial Undifferentiated Carcinoma

description: Endometrial undifferentiated carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Vulvar Carcinoma

description: Vulvar carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Advanced Prostate Carcinoma

description: A prostatic carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Vaginal Squamous Cell Carcinoma, Not Otherwise Specified

description: Vaginal squamous cell carcinoma, not otherwise specified that that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Advanced Cervical Adenosquamous Carcinoma

description: Cervical adenosquamous carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


complement C4-A deaminated 1 (human)

A complement C4-A (human) that has been deaminated on the residue at the position equivalent to Asn-1135 of the amino acid sequence represented by UniProtKB:P0C0L4-1. Example: UniProtKB:P0C0L4-1, Asn-1135, MOD:00684.


name: basal ganglia calcification, idiopathic, 1

description: An autosomal dominant condition caused by mutation(s) in the SLC20A2 gene, encoding sodium-dependent phosphate transporter 2. It is characterized by calcification of the basal ganglia.


name: blood group Rh(CE) polypeptide isoform h2e (human)

description: A blood group Rh(CE) polypeptide (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P18577-8.


name: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 isoform h3 (human)

description: A SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q92925-3.


name: ubiquitin-conjugating enzyme E2 B deaminated 2 (human)

description: A ubiquitin-conjugating enzyme E2 B (human) that has been deaminated on the residue at the position equivalent to Gln-128 of the amino acid sequence represented by UniProtKB:P63146. UniProtKB:P63146, Gln-128, MOD:00685.


name: bromodomain-containing protein 4 isoform B (human)

description: A bromodomain-containing protein 4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60885-3.


name: bromodomain-containing protein 4 isoform C (human)

description: A bromodomain-containing protein 4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60885-2.


name: bromodomain-containing protein 4 phosphorylated 1 (human)

description: A bromodomain-containing protein 4 (human) that has been phosphorylated on the residue at the position equivalent to Thr-221 of the amino acid sequence represented by UniProtKB:O60885-1. Example: UniProtKB:O60885-1, Thr-221, MOD:00047.


name: bromodomain-containing protein 4 isoform A (human)

description: A bromodomain-containing protein 4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60885-1.


name: bromodomain-containing protein 4 deaminated 1 (human)

description: A bromodomain-containing protein 4 (human) that has been deaminated on the residue at the position equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:O60885-1. Example: UniProtKB:O60885-1, Asn-162, MOD:00684.


mucin-1 isoform h9 (human)

A mucin-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P15941-9.


name: cytoplasmic dynein 1 heavy chain 1 deaminated 1 (human)

description: A cytoplasmic dynein 1 heavy chain 1 (human) that has been deaminated on the residue at the position equivalent to Asn-2067 of the amino acid sequence represented by UniProtKB:Q14204. UniProtKB:Q14204, Asn-2067, MOD:00684.


Recurrent Lymphomatoid Granulomatosis

description: The reemergence of lymphomatoid granulomatosis after a period of remission.


name: Recurrent Grade II Lymphomatoid Granulomatosis

description: The reemergence of grade II lymphomatoid granulomatosis after a period of remission.


name: Recurrent Grade I Lymphomatoid Granulomatosis

description: The reemergence of grade I lymphomatoid granulomatosis after a period of remission.


name: Recurrent Childhood Lymphomatoid Granulomatosis

description: The reemergence of lymphomatoid granulomatosis in childhood after a period of remission.


retinitis pigmentosa 2

description: Any retinitis pigmentosa in which the cause of the disease is a mutation in the RP2 gene.


RP2-related retinopathy

description: A retinopathy caused by variants in the X-linked gene, RP2.


name: Extraocular Cutaneous Sebaceous Carcinoma

description: A rare variant of sebaceous carcinoma that does not affect the ocular region.


Conjunctival Sebaceous Carcinoma

description: A rare sebaceous carcinoma that arises from the conjunctiva.


Metastatic Sebaceous Carcinoma

description: Sebaceous carcinoma that has spread from the original site of growth to other anatomic sites.


Recurrent Sebaceous Carcinoma

description: The reemergence of sebaceous carcinoma after a period of remission.


sebaceous carcinoma of salivary gland

description: A rare sebaceous carcinoma that arises from the salivary glands.


Refractory Sebaceous Carcinoma

description: Sebaceous carcinoma that is resistant to treatment.


Head and Neck Sebaceous Carcinoma

description: A sebaceous carcinoma that arises from the head and neck region.


PDPT 28:0

A 1,2-diacyl-phosphatidyldimethylpropanethiol in which the two acyl groups contain a total of 28 carbons and no double bonds.


Diacyl PDPT

A class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxy group of dimethylpropanethiol.


PDPT 14:0/14:0

A 1,2-diacyl-phosphatidyldimethylpropanethiol in which the two acyl groups both contain 14 carbons and no double bonds (tetradecanoyl).


PDPT 14:0/18:1

A 1,2-diacyl-phosphatidyldimethylpropanethiol in which the two acyl substituents at positions 1 and 2 contain 14 carbons and no double bonds (tetradecanoyl) and 18 carbons and 1 double bond (octadecenoyl) respectively.


PDPT 14:0_18:1

A 1,2-diacyl-phosphatidyldimethylpropanethiol in which one of the acyl groups contains 14 carbons and no double bonds (tetradecanoyl) and the other contains 18 carbons and 1 double bond (octadecenoyl).


PDPT 32:1

A 1,2-diacyl-phosphatidyldimethylpropanethiol in which the two acyl groups contain a total of 32 carbons and 1 double bond.


name: oxytocin-neurophysin 1 isoform 1 (human)

description: An oxytocin-neurophysin 1 isoform 1 that is encoded in the genome of human.


Tropical Disease

description: Infectious and parasitic diseases endemic in tropical and subtropical zones, including Chagas' disease, leishmaniasis, leprosy, malaria, onchocerciasis, schistosomiasis, sleeping sickness, yellow fever, and others; often water- or insect-borne.


infection by Trypanosoma gambiense

description: Trypanosomiasis caused by infection by Trypanosoma brucei gambiense.


early yaws

description: Early yaws includes primary and secondary stages of yaws, endemic tropical treponemal nonvenereal infection: development of initial lesion at inoculation site followed by widespread dissemination of treponemes and generalized secondary granulomatous lesions that may relapse repeatedly.


infection by Trypanosoma rhodesiense

description: An infection with Trypanosoma brucei rhodesiense.


late yaws

description: Late yaws is the tertiary, non-contagious stage of yaws, endemic tropical treponemal nonvenereal infection. Late yaws is characterized by destructive and deforming lesions of the skin, bones, and joints.


yaws

description: An endemic, infectious, nonvenereal disease in humans that presents mainly in children younger than 15 years. The disease occurs primarily in warm, humid, tropical areas of Africa, Asia, South America, and Oceania, among poor rural populations where conditions of overcrowding and poor sanitation prevail. Infection with Treponema pertenue, a subspecies of Treponema pallidum, causes the disease.


name: cytoplasmic protein NCK2 isoform 1 (human)

description: A cytoplasmic protein NCK2 isoform 1 that is encoded in the genome of human.


name: serine/threonine-protein kinase WNK4 isoform h2 (human)

description: A serine/threonine-protein kinase WNK4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96J92-2.


A glycosylglucose formed by a beta-(1->4)-linkage between D-mannose and D-glucose.


A carbodiimide compound having an isopropyl substituent on both nitrogen atoms.


name: autosomal recessive early-onset Parkinson disease 23

description: Any young-onset Parkinson disease in which the cause of the disease is a mutation in the VPS13C gene.


Parkinson disease 17

description: Any Parkinson disease in which the cause of the disease is a mutation in the VPS35 gene.


juvenile onset Parkinson disease 19A

description: Any Parkinson disease in which the cause of the disease is a mutation in the DNAJC6 gene.


Parkinson disease 21

description: Any hereditary late onset Parkinson disease in which the cause of the disease is a mutation in the DNAJC13 gene.


name: autosomal recessive juvenile Parkinson disease 2

description: A group of disorders which feature impaired motor control characterized by bradykinesia, muscle rigidity; tremor; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see parkinson disease), secondary parkinsonism (see parkinson disease, secondary) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the basal ganglia.


early-onset Parkinson disease 20

description: Any Parkinson disease in which the cause of the disease is a mutation in the SYNJ1 gene.


name: parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development


name: autosomal recessive early-onset Parkinson disease 7

description: Any Parkinson disease in which the cause of the disease is a mutation in the PARK7 gene.


autosomal dominant Parkinson disease 4

description: A late onset Parkinson disease that has material basis in heterozygous triplication of the alpha-synuclein gene (SNCA) on chromosome 4q22.


autosomal dominant Parkinson disease 1

description: An autosomal dominant subtype of Parkinson disease, caused by mutation(s) in the SNCA gene, encoding alpha-synuclein. Mutation(s) in the SNCA gene are responsible for PARK4 and Lewy body dementia, and have overlapping phenotypes.


name: Parkinson disease 22, autosomal dominant

description: Any Parkinson disease in which the cause of the disease is a mutation in the CHCHD2 gene.


name: autosomal recessive early-onset Parkinson disease 6

description: Any Parkinson disease in which the cause of the disease is a mutation in the PINK1 gene.


name: autosomal recessive Parkinson disease 14

description: A rare neurodegenerative disease usually presenting before the age of 30 and which is characterized by dystonia, L-dopa-responsive parkinsonism, pyramidal signs and rapid cognitive decline.


hymenolepiasis

description: A parasitic infection caused by tapeworms. Most infected individuals do not have symptoms. When symptoms appear, they include diarrhea, abdominal pain, restlessness, and irritability.


name: lys-63-specific deubiquitinase BRCC36 isoform h3 (human)

description: A lys-63-specific deubiquitinase BRCC36 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P46736-3.


name: E3 ubiquitin-protein ligase TRIP12 isoform h4 (human)

description: An E3 ubiquitin-protein ligase TRIP12 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14669-4.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663Q, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gln residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Lys-663, CHEBI:30011.


name: receptor-type tyrosine-protein kinase FLT3

description: A CSF-1/PDGF receptor-type tyrosine-protein kinase that is a translation product of the human FLT3 gene or a 1:1 ortholog thereof.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579E, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Glu residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:29972.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663R, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Arg residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Lys-663, CHEBI:29952.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835V, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:30015.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant S451F, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Phe residue at the position equivalent to Ser-451 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Ser-451, CHEBI:29997|Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant Y842H, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Tyr-842 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Tyr-842, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579E, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Glu residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:29972|Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 isoform h2 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P36888-2.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839H, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-839, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841Y, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Tyr residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-841, CHEBI:46858.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579I, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3, signal peptide removed phosphorylated 2 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has had the signal peptide removed and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969 of the amino acid sequence represented by UniProtKB:P36888-1. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594I, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-594, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F691V, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Phe-691 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-691, CHEBI:30015.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663N, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Lys-663, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3, signal peptide removed phosphorylated and ubiquitinated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has had the signal peptide removed, that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969 of the amino acid sequence represented by UniProtKB:P36888-1, and that includes at least 1 ubiquitinated lysine. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|MOD:01148.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835H, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839N, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-839, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676T, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Thr residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-676, CHEBI:30013.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592D, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asp residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-592, CHEBI:29958.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839Q, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gln residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-839, CHEBI:30011.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594L, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-594, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835N, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676S, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Ser residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-676, CHEBI:29999.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841T, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Thr residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-841, CHEBI:30013.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839N, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-839, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F691L, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Phe-691 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-691, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839Q, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gln residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-839, CHEBI:30011.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835A, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:46217.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579L, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:30006|Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant Y842C, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Cys residue at the position equivalent to Tyr-842 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Tyr-842, CHEBI:29950.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676D, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asp residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-676, CHEBI:29958.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant Y842C, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Cys residue at the position equivalent to Tyr-842 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Tyr-842, CHEBI:29950.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592A, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-592, CHEBI:46217.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835F, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Phe residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:29997.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant Y572C, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Cys residue at the position equivalent to Tyr-572 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Tyr-572, CHEBI:29950.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant A627P, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Pro residue at the position equivalent to Ala-627 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Ala-627, CHEBI:50342.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594S, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Ser residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-594, CHEBI:29999.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835A, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:46217.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592G, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gly residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Val-592, CHEBI:29947.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F691I, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Phe-691 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-691, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839H, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-839, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841K, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Lys residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-841, CHEBI:29967.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579A, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:46217|Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835G, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gly residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:29947.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant R834Q, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gln residue at the position equivalent to Arg-834 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Arg-834, CHEBI:30011.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F621L, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Phe-621 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-621, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592D, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asp residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Val-592, CHEBI:29958.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835G, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gly residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:29947.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835E, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Glu residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:29972.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594S, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Ser residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-594, CHEBI:29999.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835Y, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Tyr residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:46858.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant S451F, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Phe residue at the position equivalent to Ser-451 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Ser-451, CHEBI:29997.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594L, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-594, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841H, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-841, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841Y, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Tyr residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-841, CHEBI:46858.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835H, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594V, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-594, CHEBI:30015.


name: receptor-type tyrosine-protein kinase FLT3, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has had the signal peptide removed. UniProtKB:P36888, 27-993.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835Y, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Tyr residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:46858.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676S, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Ser residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-676, CHEBI:29999.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F691V, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Phe-691 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-691, CHEBI:30015.


name: receptor-type tyrosine-protein kinase FLT3, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has had the signal peptide removed and that has been phosphorylated on the residues at the positions equivalent to Tyr-768 and Tyr-969 of the amino acid sequence represented by UniProtKB:P36888-1. Example: UniProtKB:P36888-1, 27-993, Tyr-768/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835E, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Glu residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:29972.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676K, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Lys residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-676, CHEBI:29967.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant A848P, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Pro residue at the position equivalent to Ala-848 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Ala-848, CHEBI:50342.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841I, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-841, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835F, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Phe residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:29997.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835V, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:30015.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592G, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gly residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-592, CHEBI:29947.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841K, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Lys residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-841, CHEBI:29967.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663Q, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gln residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Lys-663, CHEBI:30011.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839G, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gly residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-839, CHEBI:29947.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579I, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:30009|Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant Y842H, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Tyr-842 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Tyr-842, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841T, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Thr residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-841, CHEBI:30013.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841I, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-841, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676T, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Thr residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-676, CHEBI:30013.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594I, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-594, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663R, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Arg residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Lys-663, CHEBI:29952.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841H, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-841, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676K, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Lys residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-676, CHEBI:29967.


name: receptor-type tyrosine-protein kinase FLT3 isoform h1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P36888-1.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663N, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Lys-663, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592A, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Val-592, CHEBI:46217.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579A, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:46217.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F691L, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Phe-691 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-691, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579L, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835N, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594V, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-594, CHEBI:30015.


name: Ras-related protein Rab-43 methylated 1 (human)

description: A Ras-related protein Rab-43 (human) that has been methylated on the residue at the position equivalent to Cys-157 of the amino acid sequence represented by UniProtKB:Q86YS6-1. Example: UniProtKB:Q86YS6-1, Cys-157, MOD:00660.


congenital aortic valve insufficiency

description: Dysfunction of the aortic valve characterized by incomplete valve closure that is present at birth.


Heart valve regurgitation

description: Dysfunction of one of the cardiac valves characterized by incomplete valve closure.


Rheumatic tricuspid valve regurgitation

description: Tricuspid valve insufficiency secondary to rheumatic fever.


name: Congenital insufficiency of pulmonary valve

description: Dysfunction of the pulmonary valve characterized by incomplete valve closure that is present at birth.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and (9Z)-octadec-9-enoyl (oleoyl) respectively.


name: pyroglutamyl-peptidase 1-like protein isoform h1 (human)

description: A pyroglutamyl-peptidase 1-like protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A6NFU8-1.


name: very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 isoform h2 (human)

description: A very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:B0YJ81-2.


name: smad2 isoform Long phosphorylated 4 (human)

description: A smad2 isoform Long phosphorylated 4 in human. This form is phosphorylated at the clusters of [S/T]P motifs within the MH1-MH2 domain linker region. UniProtKB:Q15796-1, Thr-220, MOD:00047|Ser-245/Ser-250/Ser-255, MOD:00046.


name: protein HEG homolog 1 O-glycosylated 21 (human)

description: A protein HEG homolog 1 (human) that has been O-glycosylated at the residue equivalent to Thr-492 of the amino acid sequence represented by UniProtKB:Q9ULI3-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9ULI3-1, Thr-492, MOD:00005~GNO:G43417UB.


name: collagen alpha-2(V) chain, signal peptide removed 4-hydroxy-proline and glucosylgalactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 glucosylgalactosylhydroxylated lysine and at least 3 4-hydroxy-prolines. UniProtKB:P05997, 27-1499, MOD:00039(3+)|MOD:00162.


collagen alpha-2(V) chain

A collagen type V alpha chain that is a translation product of the human COL5A2 gene or a 1:1 ortholog thereof.


name: collagen alpha-2(V) chain, signal peptide removed form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed. UniProtKB:P05997, 27-1499.


name: collagen alpha-2(V) chain O-glycosylated 1 (human)

description: A collagen alpha-2(V) chain (human) that has been O-glycosylated at the residue equivalent to Ser-188 of the amino acid sequence represented by UniProtKB:P05997-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05997-1, Ser-188, MOD:00002~GNO:G43417UB.


name: collagen alpha-2(V) chain isoform 1 (human)

description: A collagen alpha-2(V) chain isoform 1 that is encoded in the genome of human.


name: collagen alpha-2(V) chain deaminated 1 (human)

description: A collagen alpha-2(V) chain (human) that has been deaminated on the residue at the position equivalent to Gln-1099 of the amino acid sequence represented by UniProtKB:P05997. UniProtKB:P05997, Gln-1099, MOD:00685.


name: collagen alpha-2(V) chain, signal peptide removed 5-hydroxy-lysine, 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine, at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:P05997, 27-1499, MOD:00037|MOD:00038|MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:P05997, 27-1499, MOD:00038|MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed glucosylgalactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 glucosylgalactosylhydroxylated lysine. UniProtKB:P05997, 27-1499, MOD:00162.


name: collagen alpha-2(V) chain, signal peptide removed 5-hydroxy-lysine and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine and at least one 4-hydroxy-proline. UniProtKB:P05997, 27-1499, MOD:00037|MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed 3-hydroxy-proline, 4-hydroxy-proline, and glucosylgalactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 3-hydroxy-proline, at least 1 glucosylgalactosylhydroxylated lysine, and at least 3 4-hydroxy-prolines. UniProtKB:P05997, 27-1499, MOD:00038|MOD:00039(3+)|MOD:00162.


name: collagen alpha-2(V) chain 5-hydroxy-lysine, 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that includes at least one 5-hydroxy-lysine, at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:P05997, MOD:00037|MOD:00038|MOD:00039.


name: collagen alpha-2(V) chain 5-hydroxy-lysine and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that includes at least one 5-hydroxy-lysine and at least one 4-hydroxy-proline. UniProtKB:P05997, MOD:00037|MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed galactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 galactosylhydroxylated lysine. UniProtKB:P05997, 27-1499, MOD:01914.


name: collagen alpha-2(V) chain, signal peptide removed 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least one 4-hydroxy-proline. UniProtKB:P05997, 27-1499, MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed 5-hydroxy-lysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine. UniProtKB:P05997, 27-1499, MOD:00037.


name: collagen alpha-2(V) chain, signal peptide removed 3-hydroxy-proline, 4-hydroxy-proline, and galactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 3-hydroxy-proline, at least 1 galactosylhydroxylated lysine, and at least 3 4-hydroxy-prolines. UniProtKB:P05997, 27-1499, MOD:00038|MOD:00039(3+)|MOD:01914.


name: collagen alpha-2(V) chain 5-hydroxy-lysine form (human)

description: A collagen alpha-2(V) chain (human) that includes at least one 5-hydroxy-lysine. UniProtKB:P05997, MOD:00037.


name: collagen alpha-2(V) chain 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that includes at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:P05997, MOD:00038|MOD:00039.


name: collagen alpha-2(V) chain 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that includes at least one 4-hydroxy-proline. UniProtKB:P05997, MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed 4-hydroxy-proline and galactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 galactosylhydroxylated lysine and at least 3 4-hydroxy-prolines. UniProtKB:P05997, 27-1499, MOD:00039(3+)|MOD:01914.


name: retinol dehydrogenase 10 isoform 1 (human)

description: A retinol dehydrogenase 10 isoform 1 that is encoded in the genome of human.


name: Rab GTPase-binding effector protein 1 deaminated 1 (human)

description: A Rab GTPase-binding effector protein 1 (human) that has been deaminated on the residue at the position equivalent to Gln-663 of the amino acid sequence represented by UniProtKB:Q15276-1. Example: UniProtKB:Q15276-1, Gln-663, MOD:00685.


delphilin isoform 1 (human)

A delphilin isoform 1 that is encoded in the genome of human.


A sialononaosylceramide having alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc as the sialononaosyl component.


name: Golgi-associated plant pathogenesis-related protein 1 isoform 1 (human)

description: A Golgi-associated plant pathogenesis-related protein 1 isoform 1 that is encoded in the genome of human.


intracranial sinus thrombosis

description: Formation or presence of a blood clot (thrombus) in the cranial sinuses, large endothelium-lined venous channels situated within the skull. Intracranial sinuses, also called cranial venous sinuses, include the superior sagittal, cavernous, lateral, petrous sinuses, and many others. Cranial sinus thrombosis can lead to severe headache; seizure; and other neurological defects.


Arteriovenous fistula stenosis

description: Narrowing of the lumen of an arteriovenous fistula.


name: Triple-Class Refractory Multiple Myeloma

description: Multiple myeloma that is resistant to three classes of therapeutic agents, including proteasome inhibitors, immunomodulatory agents, and monoclonal antibodies.


ADP-alpha-D-ribose 1''-phosphate

The 1''-phosphate derivative of ADP-alpha-D-ribose.


ADP-D-ribose

A nucleotide-sugar having ADP as the nucleotide fragment and D-ribofuranos-5-yl as the sugar component.


ADP-L-glycero-D-manno-heptose

An ADP-glycero-D-manno-heptose having L-glycero-configuration at the 6-position of the heptose portion.


D-ribofuranosyl-ADP

An ADP-aldose having ribose as the aldose fragment.


ADP-beta-D-ribose

An ADP-D-ribose with alpha configuration at the anomeric centre.


ADP-D-glycero-beta-D-manno-heptose

The beta-anomer of ADP-D-glycero-D-manno-heptose.


ADP-L-glycero-beta-D-manno-heptose

An ADP-L-glycero-D-manno-heptose having beta-configuration at the anomeric centre of the heptose.


ADP alpha-D-glucoside

An ADP-aldose having alpha-D-glucopyranose as the sugar moiety.


ADP-D-galactose

An ADP-aldose in which the aldose component is specified as D-galactopyranose.


name: aspartate aminotransferase, mitochondrial, transit peptide removed pyridoxal phosphate lysine 1 (human)

description: An aspartate aminotransferase, mitochondrial (human) that has had the transit peptide removed and has been post-translationally modified to include pyridoxal phosphate lysine at position 279 of the amino acid sequence represented by UniProtKB:P00505. UniProtKB:P00505, 30-430, Lys-279, MOD:00128.


hydroxycarboxylic acid receptor 2

A hydroxycarboxylic acid receptor protein that is a translation product of the human HCAR2 gene or a 1:1 ortholog thereof.


name: MORC family CW-type zinc finger protein 4 phosphorylated 1 (human)

description: A MORC family CW-type zinc finger protein 4 (human) that has been phosphorylated on the residue at the position equivalent to Ser-114 of the amino acid sequence represented by UniProtKB:Q8TE76-1. Example: UniProtKB:Q8TE76-1, Ser-114, MOD:00046.


apocrine sweat gland disorder

description: A disease that involves the apocrine sweat gland.


familial acne inversa

description: An instance of hidradenitis suppurativa that is caused by an inherited modification of the individual's genome.


acne inversa, familial, 3

description: Any familial acne inversa in which the cause of the disease is a mutation in the PSEN1 gene.


acne inversa, familial, 2

description: Any familial acne inversa in which the cause of the disease is a mutation in the PSENEN gene.


apocrine adenoma

description: A benign epithelial neoplasm arising from the apocrine sweat glands. Representative examples include tubular apocrine adenoma and external auditory canal ceruminous adenoma.


apocrine sweat gland cancer

description: A malignant neoplasm involving the apocrine sweat gland.


acne inversa, familial, 1

description: Any familial acne inversa in which the cause of the disease is a mutation in the NCSTN gene.


apocrine sweat gland neoplasm

description: A benign or malignant sweat gland neoplasm with apocrine differentiation. Representative examples include apocrine adenoma, ceruminous adenocarcinoma, and apocrine breast carcinoma.


A primary alpha-hydroxy ketone that is butane-1,2-diol in which the hydroxy group at position 2 has been formally oxidised to give the corresponding ketone.


name: (10E,12Z,15Z)-9-hydroxy-10,12,15-octadecatrienoic acid methyl ester

description: A fatty acid methyl ester isolated from leaves and twigs of Ehretia dicksonii. It exhibits anti-inflammatory and inhibition of lipoxygenase activities.


neuropeptide B

A protein that is a translation product of the human NPB gene or a 1:1 ortholog thereof.


Dextrocardia Situs Solitus

description: A congenital heart defect in which the heart is located in the right side and the other organs are in their normal position.


Recurrent Childhood Pineoblastoma

description: The reemergence of pineoblastoma in childhood after a period of remission.


name: leucine-rich repeat transmembrane neuronal protein 1, signal peptide removed form (human)

description: A leucine-rich repeat transmembrane neuronal protein 1 (human) that has had the signal peptide removed. UniProtKB:Q86UE6, 35-522.


phenyl phosphate(2-)

Major microspecies at pH 7.3.


name: trafficking protein particle complex subunit 2-like protein

description: A protein that is a translation product of the human TRAPPC2L gene or a 1:1 ortholog thereof.


name: trafficking protein particle complex subunit 2-like protein isoform h1 (human)

description: A trafficking protein particle complex subunit 2-like protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UL33-1.


name: trafficking protein particle complex subunit 2-like protein isoform 2 (human)

description: A trafficking protein particle complex subunit 2-like protein isoform 2 that is encoded in the genome of human.


name: trafficking protein particle complex subunit 2-like protein cysteinylated 1 (human)

description: A trafficking protein particle complex subunit 2-like protein (human) that has been cysteinylated on the residue at the position equivalent to Cys-112 of the amino acid sequence represented by UniProtKB:Q9UL33-1. Example: UniProtKB:Q9UL33-1, Cys-112, MOD:00765.


A protein that is a translation product of the human MTHFR gene or a 1:1 ortholog thereof.


name: methylenetetrahydrofolate reductase (NADPH) isoform h2 (human)

description: A methylenetetrahydrofolate reductase (NADPH) (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P42898-2.


name: methylenetetrahydrofolate reductase (NADPH) isoform h1 (human)

description: A methylenetetrahydrofolate reductase (NADPH) (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P42898-1.


Trichomonas prostatitis

description: Infection of the prostate gland caused by Trichomonas vaginalis.


name: proton-coupled zinc antiporter SLC30A5 isoform h2 (human)

description: A proton-coupled zinc antiporter SLC30A5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TAD4-2.


P protein isoform h3 (human)

A P protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q04671-3.


name: TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 isoform h1 (human)

description: A TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q15750-1.


alpha-mannosidosis, goat

description: Alpha-mannosidosis that occurs in goat.


name: TGF-beta receptor type-1, signal peptide removed ubiquitinated form (human)

description: A TGF-beta receptor type-1 (human) that has had the signal peptide removed and that includes at least one ubiquitinated lysine. UniProtKB:P36897, 34-503, MOD:01148.


name: 1-azepanecarboxylic acid (7-chloro-4-quinolinyl) ester


name: Renal Tubular Acidosis Associated With Deafness

description: Renal tubular acidosis associated with sensorineural hearing loss, and which is typically associated with recessive mutations.


Fetal acidosis

description: An abnormally high hydrogen ion concentration (umbilical arterial blood pH less than 7.00) in fetal blood or tissue.


name: renal tubular acidosis, distal, 4, with hemolytic anemia

description: Distal renal tubular acidosis (dRTA) with anemia is a very rare form of distal renal tubular acidosis (dRTA) characterized by a defect in renal acidification and hereditary hemolytic anemia.


name: Refractory Chronic Myelomonocytic Leukemia

description: Chronic myelomonocytic leukemia that is resistant to treatment.


name: endoplasmic reticulum-Golgi intermediate compartment protein 2 isoform 1 (human)

description: An endoplasmic reticulum-Golgi intermediate compartment protein 2 isoform 1 that is encoded in the genome of human.


phospholipase DDHD1 isoform h3 (human)

A phospholipase DDHD1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NEL9-3.


A phytoceramide in which the ceramide N-acyl group is specified as octadecanoyl (stearoyl).


Wilson-Turner syndrome

description: A very rare genetic disease characterized by intellectual disability, truncal obesity, gynecomastia, hypogonadism, dysmorphic facial features, and short stature.


name: medium-chain specific acyl-CoA dehydrogenase, mitochondrial deaminated 2 (human)

description: A medium-chain specific acyl-CoA dehydrogenase, mitochondrial (human) that has been deaminated on the residue at the position equivalent to Asn-379 of the amino acid sequence represented by UniProtKB:P11310-1. Example: UniProtKB:P11310-1, Asn-379, MOD:00684.


name: gamma-soluble NSF attachment protein isoform 1 (human)

description: A gamma-soluble NSF attachment protein isoform 1 that is encoded in the genome of human.


name: bone morphogenetic protein 1 cysteinylated 3 (human)

description: A bone morphogenetic protein 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-822 of the amino acid sequence represented by UniProtKB:P13497-1. Example: UniProtKB:P13497-1, Cys-822, MOD:00765.


vigilin methylated 1 (human)

A vigilin (human) that has been methylated on the residue at the position equivalent to Cys-566 of the amino acid sequence represented by UniProtKB:Q00341-1. Example: UniProtKB:Q00341-1, Cys-566, MOD:00660.


name: leucine-rich repeat-containing protein 31 isoform h3 (human)

description: A leucine-rich repeat-containing protein 31 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6UY01-3.


name: leucine-rich repeat-containing protein 31

description: A protein that is a translation product of the human LRRC31 gene or a 1:1 ortholog thereof.


name: leucine-rich repeat-containing protein 31 isoform h2 (human)

description: A leucine-rich repeat-containing protein 31 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6UY01-2.


name: leucine-rich repeat-containing protein 31 isoform h4 (human)

description: A leucine-rich repeat-containing protein 31 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6UY01-4.


name: F-box only protein 32 isoform h2 (human)

description: An F-box only protein 32 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q969P5-2.


name: steroidogenic acute regulatory protein, mitochondrial, transit peptide removed form (human)

description: A steroidogenic acute regulatory protein, mitochondrial (human) that has had the transit peptide removed. UniProtKB:P49675, 64-285.


name: ER degradation-enhancing alpha-mannosidase-like protein 1 isoform h1 (human)

description: An ER degradation-enhancing alpha-mannosidase-like protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q92611-1.


name: angiopoietin-related protein 2 isoform 1 (human)

description: An angiopoietin-related protein 2 isoform 1 that is encoded in the genome of human.


name: angiopoietin-related protein 2 O-glycosylated 1 (human)

description: An angiopoietin-related protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-268 of the amino acid sequence represented by UniProtKB:Q9UKU9-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q9UKU9-1, Thr-268, MOD:00005~GNO:G29068FM.


name: angiopoietin-related protein 2 O-glycosylated 2 (human)

description: An angiopoietin-related protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-268 of the amino acid sequence represented by UniProtKB:Q9UKU9-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9UKU9-1, Thr-268, MOD:00005~GNO:G43417UB.


name: angiopoietin-related protein 2 isoform h2 (human)

description: An angiopoietin-related protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKU9-2.


hemopexin O-glycosylated 11 (human)

A hemopexin (human) that has been O-glycosylated at the residue equivalent to Thr-29 of the amino acid sequence represented by UniProtKB:P02790-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P02790-1, Thr-29, MOD:00005~GNO:G58001LT.


plexin-B2 cysteinylated 4 (human)

A plexin-B2 (human) that has been cysteinylated on the residue at the position equivalent to Cys-486 of the amino acid sequence represented by UniProtKB:O15031. UniProtKB:O15031, Cys-486, MOD:00765.


name: etoposide-induced protein 2.4 homolog cysteinylated 1 (human)

description: An etoposide-induced protein 2.4 homolog (human) that has been cysteinylated on the residue at the position equivalent to Cys-264 of the amino acid sequence represented by UniProtKB:O14681-1. Example: UniProtKB:O14681-1, Cys-264, MOD:00765.


etoposide-induced protein 2.4

A protein that is a translation product of the human EI24 gene or a 1:1 ortholog thereof.


name: etoposide-induced protein 2.4 homolog isoform 1 (human)

description: An etoposide-induced protein 2.4 isoform 1 that is encoded in the genome of human.


name: etoposide-induced protein 2.4 homolog isoform h2 (human)

description: An etoposide-induced protein 2.4 homolog (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O14681-3.


name: etoposide-induced protein 2.4 homolog methylated 1 (human)

description: An etoposide-induced protein 2.4 homolog (human) that has been methylated on the residue at the position equivalent to Cys-264 of the amino acid sequence represented by UniProtKB:O14681-1. Example: UniProtKB:O14681-1, Cys-264, MOD:00660.


An ultra-long-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of trans-2-triacontenoic acid.


osteogenesis imperfecta type 12

description: Any osteogenesis imperfecta in which the cause of the disease is a mutation in the SP7 gene.


name: mitogen-activated protein kinase 7 isoform h2 (human)

description: A mitogen-activated protein kinase 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13164-2.


mitogen-activated protein kinase 7

A protein that is a translation product of the human MAPK7 gene or a 1:1 ortholog thereof.


name: mitogen-activated protein kinase 7 isoform h3 (human)

description: A mitogen-activated protein kinase 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13164-3.


name: mitogen-activated protein kinase 7, initiator methionine removed form (human)

description: A mitogen-activated protein kinase 7 (human) that has had the initiator methionine removed. UniProtKB:Q13164, 2-816.


name: mitogen-activated protein kinase 7, initiator methionine removed phosphorylated 2 (human)

description: A mitogen-activated protein kinase 7 (human) that has had the initiator methionine removed and has been post-translationally modified to include phosphothreonine at position 219, and phosphotyrosine at position 221 of the amino acid sequence represented by UniProtKB:Q13164. UniProtKB:Q13164, 2-816, Thr-219, MOD:00047|Tyr-221, MOD:00048.


name: mitogen-activated protein kinase 7 isoform 1 phosphorylated 1 (human)

description: A mitogen-activated protein kinase 7 isoform 1 phosphorylated 1 in human. UniProtKB:Q13164-1, Thr-28/Thr-219/Thr-733, MOD:00047|Tyr-221, MOD:00048|Ser-421/Ser-433/Ser-496/Ser-731, MOD:00046.


name: mitogen-activated protein kinase 7 isoform h4 (human)

description: A mitogen-activated protein kinase 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13164-4.


name: mitogen-activated protein kinase 7 isoform 1 (human)

description: A mitogen-activated protein kinase 7 isoform 1 that is encoded in the genome of human.


name: keratin, type II cytoskeletal 6A, initiator methionine removed form (human)

description: A keratin, type II cytoskeletal 6A (human) that has had the initiator methionine removed. UniProtKB:P02538, 2-564.


name: heat shock protein HSP 90-alpha isoform 1 (human)

description: A heat shock protein HSP 90-alpha (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P07900-1.


cftr isoform 1 phosphorylated 2 (human)

A cftr isoform 1 phosphorylated 2 in human. Example: UniProtKB:P13569-1, Ser-686/Ser-737/Ser-768/Ser-790/Ser-795/Ser-813, MOD:00046.


mediastinum rhabdomyosarcoma

description: A malignant mesenchymal tumor with skeletal muscle differentiation affecting the mediastinum.


name: maleylacetoacetate isomerase isoform h3 (human)

description: A maleylacetoacetate isomerase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O43708-3.


name: maleylacetoacetate isomerase isoform h1 (human)

description: A maleylacetoacetate isomerase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O43708-1.


name: maleylacetoacetate isomerase isoform h2 (human)

description: A maleylacetoacetate isomerase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O43708-2.


name: Rho GTPase-activating protein 5 deaminated 1 (human)

description: A Rho GTPase-activating protein 5 (human) that has been deaminated on the residue at the position equivalent to Gln-1471 of the amino acid sequence represented by UniProtKB:Q13017-1. Example: UniProtKB:Q13017-1, Gln-1471, MOD:00685.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 23 carbons and 0 double bonds and is 2-hydroxylated.


name: RanBP-type and C3HC4-type zinc finger-containing protein 1 isoform h2 (human)

description: A RanBP-type and C3HC4-type zinc finger-containing protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BYM8-3.


magnesium transporter NIPA2

A protein that is a translation product of the human NIPA2 gene or a 1:1 ortholog thereof.


name: magnesium transporter NIPA2 isoform h1 (human)

description: A magnesium transporter NIPA2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N8Q9-1.


name: magnesium transporter NIPA2 isoform h2 (human)

description: A magnesium transporter NIPA2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N8Q9-2.


name: magnesium transporter NIPA2 citrullinated 1 (human)

description: A magnesium transporter NIPA2 (human) that has been citrullinated on the residue at the position equivalent to Arg-353 of the amino acid sequence represented by UniProtKB:Q8N8Q9-1. Example: UniProtKB:Q8N8Q9-1, Arg-353, MOD:00219.


name: zinc finger protein 513 isoform 1 (human)

description: A zinc finger protein 513 isoform 1 that is encoded in the genome of human.